探讨重组促红细胞生成素药理作用的评价方法

详细信息

收稿日期: 2012-03-02

Evaluation methods of recombinant human erythropoietin pharmacological action

- 1. Huangshi Center for Clinical Laboratory, Huangshi, 435000, China;
- 2. Medical School, Huangshi Institute of Technology;
- 3. Huangshi Health Hospital

More Information

Received Date: 02 March 2012

摘要: 目的:探讨重组人促红细胞生成素(rhEPO)对小鼠药理作用的评价方法。方法:煌焦油蓝染色法计数网织红细胞的数量;自动血细胞计数仪分析平均血红蛋白(MCH)的含量。结果:小鼠年龄对结果影响较大,90 d以上的小鼠测定结果较稳定;通过比较小鼠肝脏、脾脏及血液的网织红细胞的数量发现,脾脏对红细胞生成素最敏感;红细胞MCH的含量可以间接反应机体内促红细胞生成素的治疗效果。结论:小鼠体内促红细胞生成素的治疗效果可以通过网织红细胞计数和体外MCH的含量来判断。
- 促红细胞生成素 /
- 网织红细胞 /
- 煌焦油蓝 /
- 平均血红蛋白
Abstract: Objective:To explore the evaluation methods of recombinant human erythropoietin pharmacological action for jimpy mice.Method:Reticulocyte quantity was counted with brilliant cresol blue staining method. MCH level was analyzed by blood cell counter.Result:Jimpy mice age had greater impact on the results. The result of above 90 days was stable. Comparison of Jimpy mice liver,spleen and blood reticulocyte number,spleen was the most sensitive. MCH could indirectly reflect the therapeutic efficacy of rhEPO.Conclusion:The therapeutic efficacy of rhEPO could be judged with reticulocyte quantity and MCH.
- erythropoietin /
- reticulocyte /
- brilliant cresol blue /
- Mean corpuscular hemoglobin

[1]	SCHMIDT W,BIERMANN B,WINCHENBACH P,et al.Int[J].Sports Med,2000,2:133-138.
[2]	叶应妩,王毓三,申子瑜.全国临床检验操作规程[M].3版.南京:东南大学出版社,2006:130-132.
[3]	王彬,宓捷波,常文保,等.EPO检测技术的研究进展[J].化学进展,2005,15(2):117-122.
[4]	BREYMANN C.Bailliere’s.Clin Endocrinol Metab,2000,14:135-138.
[5]	刘志贤,李剑鸿,曾建武.例新生儿网织红细胞计数参考范围的探讨[J].生物医学工程与临床,2008,6(12):487-489.
[6]	周建中.红细胞参数在缺铁性贫血诊断中的应用评价[J].国际检验医学杂,2006,32(7):805-806.
[7]	JELKMANN W.Erythropoietin after a century of research:younger than ever[J].Eur J Haematol,2007,78:183-205.
[8]	HIRAKATA H,YAO H,OSATO S,et al.CBF and oxygen metabolism in hemodialysis patients:effects of anemia correction with recombinant human EPO[J].Am J Physiol,1992,262:737-743.
[9]	BRINES M,GHEZZI P,KEENAN S,et al.Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury[J].Proc Natl Acad Sci,2000,97:526-531.
[10]	ERBAYRAKTAR S,GRASSO G,SFACTERIA A,et al.Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo[J].Proc Natl Acad Sci,2003,100:741-746.